Company news

STAAR Surgical Company news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

STAAR Surgical Reports Preliminary Sales for Fourth Quarter and Fiscal 2022

January 8, 2023

STAAR Surgical CEO Caren Mason to Retire; Tom Frinzi Appointed New CEO

December 18, 2022

STAAR Surgical Opens EVO Experience Center in United States

November 16, 2022

STAAR Surgical Reports Third Quarter Net Sales of $76 Million Up 30% Y/Y

November 1, 2022

STAAR Surgical to Report Third Quarter Results on November 2, 2022

October 18, 2022

Professional Basketball Player Max Strus Kicks Off New Season With Upgraded Vision From Life-Changing EVO ICL Lenses

October 11, 2022

STAAR Surgical Patient Awareness Campaign Launched In New York

September 13, 2022

STAAR Surgical Reports Record Second Quarter Net Sales of $81.1 Million Up 30% Y/Y

August 9, 2022

STAAR Surgical and Joe Jonas Team Up to Introduce New Life-Changing EVO ICL to Millions of Americans Suffering from Distance Vision Problems

August 9, 2022

STAAR Surgical to Report Second Quarter Results on August 10, 2022

July 19, 2022

STAAR Surgical Celebrates Two Million Lens Milestone for Implantable Collamer® Lens (ICL)

June 6, 2022

STAAR Surgical Reports Record First Quarter Net Sales of $63.2 Million Up 25% Y/Y

May 3, 2022

STAAR Surgical to Report First Quarter Results on May 4, 2022

April 19, 2022

STAAR Surgical Announces First Implants of EVO Visian ICL in the U.S.

April 5, 2022

STAAR Surgical Announces U.S. FDA Approval of EVO Visian® Implantable Collamer® Lenses

March 27, 2022

STAAR Surgical Reports Fourth Quarter and Full Year 2021 Results

February 22, 2022

STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 23, 2022

February 8, 2022

STAAR Surgical Announces Preliminary Fourth Quarter and Full Year 2021 Results

January 9, 2022

STAAR Surgical Reports Third Quarter Net Sales of $58.4 Million Up 24% Y/Y

November 2, 2021

STAAR Surgical to Report Third Quarter Results on November 3, 2021

October 19, 2021

STAAR Surgical Reports Record Second Quarter Net Sales of $62.4 Million Up 77% Y/Y and Increases Outlook for 2021

August 3, 2021

STAAR Surgical to Report Second Quarter Results on August 4, 2021

July 20, 2021

STAAR Surgical Reports Record First Quarter 2021 Net Sales of $50.8 Million Up 44% Y/Y

May 4, 2021

STAAR Surgical to Report First Quarter Results on May 5, 2021

April 20, 2021

STAAR Surgical Reports Fourth Quarter and Full Year 2020 Results

February 23, 2021

STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 24, 2021

February 9, 2021

Elizabeth Yeu, M.D. and K. Peony Yu, M.D. Appointed to STAAR Surgical Board of Directors

January 25, 2021

STAAR Surgical Announces Preliminary Fourth Quarter and Full Year 2020 Results

January 9, 2021

STAAR Surgical Reports Third Quarter 2020 Results

November 3, 2020

STAAR Surgical Begins Commercialization of EVO Viva™ Presbyopia Correcting Lens

November 3, 2020

STAAR Surgical to Report Third Quarter Results on November 4, 2020

October 20, 2020

STAAR Surgical Announces Completion of Patient Enrollment in EVO Implantable Lens US Clinical Trial

September 13, 2020

STAAR Surgical Reports Second Quarter 2020 Results

August 4, 2020

STAAR Surgical to Report Second Quarter Results on August 5, 2020

July 21, 2020

STAAR Surgical Company to Hold 2020 Annual Meeting of Shareholders in Virtual Format

July 13, 2020

STAAR Surgical Introduces EVO Viva™ Presbyopia Correcting Lens – See Young Again!

July 6, 2020

Patrick F. Williams Appointed Chief Financial Officer of STAAR Surgical

July 5, 2020

Dr. Gil Kliman and Tom Frinzi Appointed to STAAR Surgical Board of Directors

May 31, 2020

STAAR Surgical Reports First Quarter 2020 Results

May 5, 2020

STAAR Surgical to Report First Quarter Results on May 6, 2020

April 14, 2020

STAAR Surgical Provides COVID-19 Business Update

April 12, 2020

STAAR Surgical Reports Fourth Quarter and Full Year 2019 Results

February 25, 2020

STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 26, 2020

February 4, 2020

STAAR Surgical Announces Strategic Cooperation Agreement with Senshinkai Eye Institute, A Leading Eye Care Chain in Japan

February 4, 2020

STAAR Surgical Announces the EVO Implantable Lens US Clinical Trial is Underway with 1st Patient Implanted at Price Vision Group in Indianapolis on January 30th

February 3, 2020

STAAR CFO to Retire in 2020

December 17, 2019

STAAR Surgical Announces Strategic Alliance Agreement with California Center for Refractive Surgery (CCRS)

December 16, 2019

STAAR Surgical Announces FDA IDE Clinical Study Approval

December 10, 2019

STAAR Surgical to Host Investor and Analyst Day on November 8, 2019

November 5, 2019

STAAR Surgical Reports Third Quarter Results

October 29, 2019

← Newer news releases · Older news releases →

Calls

The 5 newest of 22 calls. Every call is listed under its year.

Decks

The 5 newest of 85 decks. Every deck is listed under its year.